CRESCENT BIOPHARMA, INC. (CBIO) › RevenueCRESCENT BIOPHARMA, INC. (CBIO) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2025$10.84M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share